Holly L Peay
Overview
Explore the profile of Holly L Peay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cope H, Milko L, Jalazo E, Crissman B, Foreman A, Powell B, et al.
Genet Med
. 2024 Oct;
26(12):101290.
PMID: 39375994
Purpose: Research is underway worldwide to investigate the feasibility, acceptability, and utility of sequencing-based newborn screening. Different methods have been used to select gene-condition pairs for screening, leading to highly...
2.
Villalobos A, Reynolds E, Halpin S, Jacobs S, Peay H
Implement Sci Commun
. 2024 Jul;
5(1):78.
PMID: 39026346
Background: There has been increased attention to the need for, and the positive impact of, engaged or participatory science in recent years. Implementation scientists have an opportunity to leverage and...
3.
Potter S, Migliore B, Carter J, Copeland V, Smith E, Peay H, et al.
Int J Neonatal Screen
. 2024 Jun;
10(2).
PMID: 38920848
Duchenne muscular dystrophy (DMD) is an X-linked progressive disorder and the most common type of muscular dystrophy in children. As newborn screening (NBS) for DMD undergoes evaluation for the Recommended...
4.
Hunt J, Peay H, Henderson G
AIDS Behav
. 2024 May;
28(9):2910-2925.
PMID: 38767727
In 2022, 54% of 1.5 million children (age 0-14) living with HIV had access to anti-retroviral medication (ART). Adherence to ART for pregnant or breastfeeding HIV + women is critical...
5.
van Til J, Pearce A, Ozdemir S, Hollin I, Peay H, Wu A, et al.
Patient
. 2023 Oct;
17(1):3-12.
PMID: 37874464
Health preference research (HPR) is being increasingly conducted to better understand patient preferences for medical decisions. However, patients vary in their desire to play an active role in medical decisions....
6.
Kucera K, Boyea B, Migliore B, Potter S, Robles V, Kutsa O, et al.
Genet Med
. 2023 Oct;
26(1):101009.
PMID: 37864479
Purpose: Current and emerging treatments for Duchenne muscular dystrophy (DMD) position DMD as a candidate condition for newborn screening (NBS). In anticipation of the nomination of DMD for universal NBS,...
7.
van Paassen P, Dijkstra M, Peay H, Rokx C, Verbon A, Reiss P, et al.
AIDS Res Hum Retroviruses
. 2023 Oct;
40(5):286-292.
PMID: 37791419
Starting antiretroviral therapy (ART) same-day, or as soon as possible after HIV diagnosis is advised in guidelines worldwide. Especially during acute HIV infection (AHI), rapid ART start may be more...
8.
Okumu E, Henderson G, Golin C, Kuczynski K, Ormsby N, Peay H
J Virus Erad
. 2023 Aug;
9(3):100340.
PMID: 37560051
[This corrects the article DOI: 10.1016/j.jve.2023.100331.].
9.
Okumu E, Henderson G, Golin C, Kuczynski K, Ormsby N, Peay H
J Virus Erad
. 2023 Jul;
9(2):100331.
PMID: 37416088
Early-phase HIV remission ("cure") trials aim to test interventions developed to eradicate HIV or to sustainably control HIV without antiretroviral treatment (ART). Many remission trials include analytic treatment interruption (ATI)...
10.
Hallquist M, Borensztein M, Coughlin 2nd C, Buchanan A, Andrew Faucett W, Peay H, et al.
Eur J Hum Genet
. 2023 Jun;
31(10):1165-1174.
PMID: 37308598
The Clinical Genome Resource (ClinGen) Consent and Disclosure Recommendation (CADRe) framework proposes that key components of informed consent for genetic testing can be covered with a targeted discussion for many...